insights_auto
Bakit tumaas ang OCEA 200.00%?
Tingnan ang Higit pang Detalyechevron_right
OCEA:OTCMKTS
Ocean Biomedical Inc
$0.00060
arrow_upward
+200.00%(+0.00040) 1D
Okt 16, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa OCEA...
Buksan
$0.00
Mataas
$0.00
Mababa
$0.00
Mkt. cap
96.20K
Avg. na dami
51.94K
Dami
312.00
Mataas nang 52-wk
$0.01
Mababa nang 52-wk
$0.00
Beta
2.65
Mga natitirang share
232.36M
Bilang ng mga empleyado
7
Buksan
$0.00
Mataas
$0.00
Mababa
$0.00
Mkt. cap
96.20K
Avg. na dami
51.94K
Dami
312.00
Mataas nang 52-wk
$0.01
Mababa nang 52-wk
$0.00
Beta
2.65
Mga natitirang share
232.36M
Bilang ng mga empleyado
7
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
The Motley Fool
·
3 araw ang nakalipas
Intel Stock Has Nearly Tripled in 2026. A $10,000 Stake From 2016 Still Trails the S&P 500.
24/7 Wall St.
·
3 araw ang nakalipas
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
MarketWatch
·
1 buwan ang nakalipas
The S&P 500 keeps climbing on days when stocks broadly struggle. Here’s what’s going on.
Reuters
·
1 buwan ang nakalipas
S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Tungkol sa Ocean Biomedical Inc